HWP
IART icon

Highline Wealth Partners’s Integra LifeSciences IART Stock Holding History

Highline Wealth Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-85
Closed -$1.87K – 978
2025
Q1 		$1.87K Buy
+85
New +$2K ﹤0.01% 643

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Highline Wealth Partners's IART Position: Q2 2025 in Review

Highline Wealth Partners sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 85 shares — an estimated $1.87K sold.

Highline Wealth Partners first reported a position in IART in Q1 2025 and held it in 1 quarter. The position peaked at $1.87K in Q1 2025. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

  • Highline Wealth Partners reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Highline Wealth Partners sold 85 Integra LifeSciences shares in Q2 2025, an estimated $1.87K.
  • Highline Wealth Partners first reported a position in Integra LifeSciences in Q1 2025 and held it in 1 quarter.
  • Highline Wealth Partners's Integra LifeSciences position peaked at $1.87K in Q1 2025.
  • 208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Highline Wealth Partners's 13F filing for Q2 2025, filed 16 Jul 2025.